Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Importance of medication adherence to peginterferon-ribavirin combination therapy in patients with chronic hepatitis C].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi - 25 May 2011

Goh Pyung Gohn, Kim Min Jung, Kim Hye Jin, Eun Hyuk Soo, Kim Eui Sik, Kim Yun Jeung, Lee Soo Youn, Moon Hee Seok, Lee Eaum Seok, Kim Seok Hyun, Lee Byung Seok, Lee Heon Young

Abstract excerpt

BACKGROUND/AIMS: The combination therapy with peginterferon and ribavirin is a standard treatment for patients with chronic hepatitis C. However, because of the long duration of the treatment and many complications, the reduction of adherence frequently occur. This study aimed to assess influences of reduced medication adherence in the combination therapy of chronic hepatitis C patients. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Medication Adherence

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 21623138
DOI: 10.4166/kjg.2011.57.5.294

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Importance of medication adherence to peginterferon-ribavirin combination therapy in patients with chronic hepatitis C].PMID 21623138Read ↗

Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.Semantic proximity Read ↗

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.Semantic proximity Read ↗

[Effectiveness of pegylated interferon alfa 2a and ribavirin for chronic hepatitis C in clinical practice].Semantic proximity Read ↗

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice.Semantic proximity Read ↗

[Effectiveness and complications of combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C].Semantic proximity Read ↗

[Virological response of chronic hepatitis C management with peg-interferon alpha-2b and ribavirin].Semantic proximity Read ↗

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.Semantic proximity Read ↗

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.Semantic proximity Read ↗

[Efficacy of peginterferon and ribavirin combination therapy of chronic hepatitis C: a pooled analysis].Semantic proximity Read ↗

A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms.Semantic proximity Read ↗

Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study.Semantic proximity Read ↗

Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.